41 related articles for article (PubMed ID: 14604833)
1. Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B.
Ohsaki Y; Cheng J; Fujita A; Tokumoto T; Fujimoto T
Mol Biol Cell; 2006 Jun; 17(6):2674-83. PubMed ID: 16597703
[TBL] [Abstract][Full Text] [Related]
2. Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases.
Chaudhary R; Walder KR; Hagemeyer CE; Kanwar JR
Curr Atheroscler Rep; 2018 Jul; 20(9):46. PubMed ID: 30019290
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride Metabolism in the Liver.
Alves-Bezerra M; Cohen DE
Compr Physiol; 2017 Dec; 8(1):1-8. PubMed ID: 29357123
[TBL] [Abstract][Full Text] [Related]
4. β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.
Zigmond E; Tayer-Shifman O; Lalazar G; Ben Ya'acov A; Weksler-Zangen S; Shasha D; Sklair-Levy M; Zolotarov L; Shalev Z; Kalman R; Ziv E; Raz I; Ilan Y
J Inflamm Res; 2014; 7():151-8. PubMed ID: 25336983
[TBL] [Abstract][Full Text] [Related]
5. Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.
Couture P; Tremblay AJ; Kelly I; Lemelin V; Droit A; Lamarche B
J Lipid Res; 2014 Jan; 55(1):128-37. PubMed ID: 24142110
[TBL] [Abstract][Full Text] [Related]
6. Gut triglyceride production.
Pan X; Hussain MM
Biochim Biophys Acta; 2012 May; 1821(5):727-35. PubMed ID: 21989069
[TBL] [Abstract][Full Text] [Related]
7. Overproduction of large VLDL particles is driven by increased liver fat content in man.
Adiels M; Taskinen MR; Packard C; Caslake MJ; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson SO; Yki-Järvinen H; Borén J
Diabetologia; 2006 Apr; 49(4):755-65. PubMed ID: 16463046
[TBL] [Abstract][Full Text] [Related]
8. Lipid and lipoprotein dysregulation in insulin resistant states.
Avramoglu RK; Basciano H; Adeli K
Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
[TBL] [Abstract][Full Text] [Related]
9. Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
Zoltowska M; Ziv E; Delvin E; Lambert M; Seidman E; Levy E
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):118-23. PubMed ID: 14604833
[TBL] [Abstract][Full Text] [Related]
10. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
[TBL] [Abstract][Full Text] [Related]
13. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Jin UH; Kang YJ; Chang YC; Kim CH
J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
